KRM Ayurveda IPO — Listing Performance
KRM Ayurveda had a strong market debut, ending listing day 33.85% over the issue price, after heavy overall subscription of 52.19x.
KRM Ayurveda IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 21-Jan-2026 |
| Listing date | 29-Jan-2026 |
| Issue size | ₹69.74 crore |
| Overall subscription | 52.19x |
| Issue price | ₹135 |
| Listing-day close | ₹180.70 (33.85%) |
| Recent market price | ₹256.55 (90.04% vs issue) |
| 52-week range | ₹156.15 – ₹271 |
| Identifiers | NSE: KRMAYURVED · ISIN: INE1MTV01019 |
Figures are compiled from public market data and refreshed when our dataset updates. Verify against BSE/NSE records before acting on them.
How the listing went
KRM Ayurveda opened for subscription on 21-Jan-2026 as a SME issue raising about ₹70 crore. The shares were priced at ₹135 and made their debut on 29-Jan-2026, closing the first session at ₹180.70 — a listing-day change of 33.85%.
As of our last data refresh the stock trades around ₹256.55, 90.04% above the issue price.
Every IPO in our archive gets this same treatment: real issue data, the actual listing-day result, and where the price stands now — so you can judge how debut hype translated into outcomes. Compare more debuts on the IPO listing-performance archive or check live grey-market sentiment on the GMP board.
KRM Ayurveda IPO FAQs
What was the KRM Ayurveda IPO listing price?
KRM Ayurveda closed at ₹180.70 on its listing day (29-Jan-2026), against an issue price of ₹135 — a listing-day change of 33.85%.
How many times was the KRM Ayurveda IPO subscribed?
The issue was subscribed about 52.19 times overall.
Was the KRM Ayurveda IPO profitable for allottees?
On listing day, yes: allottees who sold at the closing price made about 33.85% over the issue price. Longer-term outcomes depend on when shares were sold.